Leela Paris

Vice President, Process Engineering and Manufacturing, VCGT CMC Cell Manufacturing, • Vertex Cell and Gene Therapies

Leela is a leader within Vertex Cell and Genetic Therapies, where she oversees production and development of its type 1 diabetes and sickle cell disease/beta thalassemia therapies. This includes oversight of the facility, production space, equipment validations, digital systems, supply chain and manufacturing processes — all of which require exceptional cross-functional collaboration and a relentless pursuit of excellence.

Early on, Leela knew she wanted to pursue a career that could help patients, which led her to pursue degrees in medicinal chemistry and molecular pharmacology. What drew her to Vertex? A chance meeting at a conference and a conversation about the science and the work and leadership focused on data, science and biology. Her strong work ethic and track record of success has enabled her to grow and progress in her career, including making the transition from a technical track to a managerial track.

She continues to lead by example, develop her skills (through mentorship and manager training support from Vertex), and give back to other women through IWILL (Inspiring Women in Leadership and Learning), Vertex’s employee resource network dedicated to attracting, retaining, developing and enhancing the career satisfaction of women and contributing to their professional advancement.

Also Speaking

Jacob Becraft

Co-Founder & CEO • Strand Therapeutics

Anne Cox

Director of Business Development • Tensentric

Adam Mcleod

Senior Scientist • Cytiva

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.